News
Pfizer and its German partner BioNTech asked London's Court of Appeal on Thursday to overturn a ruling that their COVID-19 ...
While money from Covid vaccine sales is a key driver of the dispute, the patent battle could prove influential for the development of future mRNA-based products.
As COVID vaccine patent dispute drags on, Moderna forks over $400M to NIH Moderna called the sum a "catch-up payment" for borrowing a molecular technique.
A legal battle between rival developers of Covid-19 jabs over vaccine technology patents has produced a mixed ruling from a High Court judge.
Covid-19 vaccine patent legal battle heading to Court of Appeal - Moderna, Pfizer and BioNTech are locked in dispute over the rights to vaccine technology patents.
The lawsuit, filed by Moderna, sets up a clash between rival vaccine makers who used novel mRNA technology to speed delivery of shots.
Acuitas Therapeutics settles lawsuit with CureVac over COVID-19 vaccine patents. Legal disputes unfold among biotech giants Pfizer, BioNTech, and CureVac, as GSK joins the fray, alleging patent ...
Moderna wins a crucial legal battle at the European Patent Office against Pfizer and BioNTech over Covid-19 vaccine patents.
Moderna has won a case at the European Patent Office in its dispute with Pfizer and BioNTech over its Covid-19 vaccine, in a boon for the mRNA-vaccine maker in its ongoing legal fight to recoup ...
One of the companies that developed mRNA vaccines for Covid-19, Moderna, has just sued the companies who make the other mRNA vaccine, Pfizer and BioNTech, claiming a violation of patents. Hey ...
European Patent Office Sides with Moderna In COVID-19 Vaccine Patent Dispute With Pfizer/BioNTech Vandana Singh Fri, May 17, 2024, 2:46 PM2 min read ...
Covid-19 vaccine patent legal battle heading to Court of Appeal Moderna, Pfizer and BioNTech are locked in dispute over the rights to vaccine technology patents.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results